Senti Biosciences effectuates 1-for-10 reverse stock split effective July 17, 2024

Senti Biosciences, Inc.

Reverse stock split at 1-for-10 ratio approved by Board on July 10, 2024.
Effective 5:00 p.m. ET on July 17, 2024; trading on split-adjusted basis begins July 18 under symbol SNTI.
No fractional shares issued; cash payment in lieu at July 17 closing price.
Authorized shares and par value remain unchanged; new CUSIP is 81726A209.
Reverse split intended to maintain Nasdaq listing compliance; proportional adjustments to equity awards.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.